203641 Sigma-AldrichBMP-2, Human, Recombinant, E. coli
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
Purity |
---|
≥95% by SDS-PAGE |
Product Information | |
---|---|
Form | Lyophilized |
Formulation | Lyophilized from sterile 10 mM sodium citrate, pH 3.5. |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Purity | ≥95% by SDS-PAGE |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
203641 | 0 |
Documentation
BMP-2, Human, Recombinant, E. coli Ficha datos de seguridad (MSDS)
Título |
---|
BMP-2, Human, Recombinant, E. coli Certificados de análisis
Cargo | Número de lote |
---|---|
203641 |
Referencias bibliográficas
Visión general referencias |
---|
Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629. Kumagai, T., et al. 2006. Anticancer Res. 26, 293. Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285. Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119. Morin, R., et al. 2006. Biomacromolecules 7, 131. Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436. |